10 Best NYSE Stocks to Buy According to Wall Street Analysts
On May 11, Ed Yardeni, Yardeni Research President, appeared on CNBC's 'Squawk Box' to discuss his increasingly bullish outlook for the stock market.
Coupang Inc. (CPNG)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tiger Global Management LLC Chase Coleman And Feroz Dewan | 34,595,407 | $653,161,284 | +32% | 2.86% |
| 2. | Greenoaks Capital Neil Mehta | 25,704,927 | $485,309,022 | +68% | 21.13% |
| 3. | Holocene Advisors Brandon Haley | 18,140,654 | $342,495,548 | -19% | 0.83% |
| 4. | Eminence Capital Ricky Sandler | 15,510,784 | $292,843,602 | +23% | 6.71% |
| 5. | Foxhaven Asset Management Michael Pausic | 14,848,868 | $280,346,628 | -14% | 8.8% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.40 | 2,332,863 | $42,923,279.48 | 55,310,977 | 2026-03-13 | Filing | |
| $18.68 | 3,000,000 | $56,036,100.00 | 52,978,114 | 2026-03-12 | Filing | |
| $18.64 | 2,017,241 | $37,603,591.21 | 49,978,114 | 2026-03-11 | Filing | |
| $26.86 | 650,000 | $17,458,610.00 | 55,131,161 | 2025-05-15 | Filing | |
| $26.78 | 750,000 | $20,082,300.00 | 54,481,161 | 2025-05-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.62 | 2,679 | $63,277.98 | 122,096 | 2026-01-02 | Filing | |
| $29.02 | 75,350 | $2,186,619.33 | 1,941,590 | 2025-11-10 | Filing | |
| $31.98 | 11,653 | $372,608.17 | 147,023 | 2025-11-03 | Filing | |
| $32.05 | 21,428 | $686,767.40 | 0 | 2025-09-11 | Filing | |
| $32.06 | 64,755 | $2,075,792.76 | 449,569 | 2025-09-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 289,542,259 | $5,466,557,850 | 70.74% | |
| 2. | 120,656,242 | $2,277,989,849 | 2.33% | |
| 3. | 72,008,120 | $1,359,513,306 | 0.75% | |
| 4. | 64,884,278 | $1,225,015,175 | 0.02% | |
| 5. | 56,145,303 | $1,060,023,379 | 0.06% |
News See All
Coupang, Inc. (NYSE:CPNG) Q1 2026 Earnings Call Transcript
Operator: Hello, everyone. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to the Coupang 2026 First Quarter Earnings Conference Call.
Is Coupang, Inc. (CPNG) A Good Stock To Buy Now?
Is CPNG a good stock to buy? We came across a bullish thesis on Coupang, Inc. on r/stocktradingideas by Variant_Invest. In this article, we will summarize the bulls’ thesis on CPNG.
Billionaire Druckenmiller and Jim Cramer Like These Stocks
Stanley Druckenmiller and Jim Cramer are two of the closely followed voices in financial markets. Though sometimes their stock preferences differ, they always draw widespread investor attention.
David Abrams' Hedge Fund Is Betting On These 8 Stocks
The US equity market remains on edge as the global geopolitical environment remains uncertain.
Here’s Why Oakmark Funds Established a Position in Coupang (CPNG)
Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” first-quarter 2026 investor letter.
10 Best Stocks to Buy According to AI Bull Brad Gerstner
Brad Gerstner of Altimeter has been one of the most vocal bulls on the AI boom, having consistently rejected Wall Street’s skepticism on valuations and bubble fears.
10 High PE Stocks Insiders Are Buying
High PE stocks are usually harder to defend in a market that has become more selective.
12 Best Stocks to Buy According to Billionaire David Abrams
David Abrams of Abrams Capital Management has remained one of the most private super-investors in the industry.
Here's What Hurt Coupang (CPNG) in Q4
Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center